Prescient Therapeutics Limited Stock
Stocks
PTX
AU000000PTX3
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
08:10:31 09/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0660 AUD | 0.00% |
|
0.00% | -21.43% |
| 09-23 | Prescient Therapeutics Raises Around AU$4.8 Million Via Share Purchase Plan, AU$1.2 Million in Shortfall Placement | MT |
| 09-18 | Prescient Therapeutics Limited - Special Call |
| Market Cap | 75.49M 52.5M 46.89M 43.74M 39.73M 74.77M 5.08B 525M 205M 2.58B 197M 193M 8.31B | P/E 2025 |
-4.84x | P/E 2026 | -8.94x |
|---|---|---|---|---|---|
| Enterprise Value | 66.67M 46.37M 41.4M 38.63M 35.09M 66.03M 4.49B 464M 181M 2.28B 174M 170M 7.34B | EV / Sales 2025 |
6.54x | EV / Sales 2026 | 16x |
| Free-Float |
94.93% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PTX | Delayed | |
Deutsche Boerse AG
| UDD | Delayed |
Last Transcript: Prescient Therapeutics Limited
| Current month | -1.49% | ||
| 1 month | +1.54% | ||
| 3 months | -9.59% | ||
| 6 months | +29.41% | ||
| Current year | -21.43% |
| 1 week | 0.06 |  | 0.07 |
| 1 month | 0.06 | | 0.07 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.04 | | 0.12 |
| 3 years | 0.04 | | 0.12 |
| 5 years | 0.04 | | 0.3 |
| 10 years | 0.02 | | 0.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 20/01/2025 | |
Melanie Leydin
DFI | Director of Finance/CFO | 53 | - |
Rosalind Wilson
CTO | Chief Tech/Sci/R&D Officer | - | 13/07/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
James Campbell
CHM | Chairman | - | 30/03/2025 |
Allen Ebens
BRD | Director/Board Member | - | 01/06/2020 |
Ellen Feigal
BRD | Director/Board Member | 71 | 15/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/2/23 A | Exercice | Chief Executive Officer | 1,148,936 | 0.1430% | ||
| 5/2/23 A | Expiration | Chief Executive Officer | 2,351,064 | 0.2926% | ||
| 4/4/23 A | Exercice | Chief Executive Officer | 97,692 | 0.0135% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +50.00% | +15.79% | 52.5M | |
| -3.19% | -3.19% | +44.60% | +87.98% | 72.13B | |
| -15.86% | -16.16% | +2.68% | +50.90% | 49.41B | |
| -2.39% | +0.50% | +3.41% | +31.33% | 47.24B | |
| -6.35% | -8.63% | +293.39% | +651.28% | 40.32B | |
| +0.30% | -0.71% | +29.05% | +30.33% | 42.61B | |
| -3.82% | -2.41% | -0.27% | +101.36% | 39.81B | |
| -2.13% | -2.18% | +7.51% | +50.31% | 30.52B | |
| -3.35% | -4.95% | -13.38% | -17.22% | 23.13B | |
| -5.27% | +1.86% | +12.19% | -5.34% | 21.09B | |
| Average | -4.21% | -3.29% | +42.92% | +99.67% | 36.63B | |
| Weighted average by Cap. | -4.85% | -3.85% | +45.72% | +117.26% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 4.36M 3.03M 2.71M 2.52M 2.29M 4.31M 293M 30.3M 11.85M 149M 11.38M 11.13M 480M | 3.45M 2.4M 2.14M 2M 1.82M 3.42M 232M 24.01M 9.39M 118M 9.01M 8.82M 380M |
| Net income | -7.32M -5.09M -4.55M -4.24M -3.85M -7.25M -493M -50.93M -19.92M -251M -19.12M -18.71M -806M | -7M -4.87M -4.35M -4.06M -3.69M -6.94M -472M -48.71M -19.05M -240M -18.29M -17.89M -771M |
| Net Debt | -6.93M -4.82M -4.3M -4.01M -3.65M -6.86M -467M -48.18M -18.85M -237M -18.09M -17.69M -762M | -8.83M -6.14M -5.48M -5.11M -4.64M -8.74M -594M -61.39M -24.01M -302M -23.04M -22.54M -971M |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/10/26 | A$0.0660 | 0.00% | 736,346 |
| 08/10/26 | A$0.0660 | +1.54% | 501,512 |
| 07/10/26 | A$0.0650 | 0.00% | 536,706 |
| 06/10/26 | A$0.0650 | +1.56% | 489,319 |
| 05/10/26 | A$0.0640 | -3.03% | 245,972 |
- Stock Market
- Stocks
- PTX Stock
Select your edition
All financial news and data tailored to specific country editions
